According to previous studies, AT1R antagonists, angiotensin II receptor blockers (ARBs) or sartans have neuroprotective effects after stroke, inflammatory brain, neurodegenerative diseases, and brain injury [38, 68–70]. This evidence concerns the gene AGTR1 and stroke disorder.